Clinical Trials Directory

Trials / Completed

CompletedNCT02144740

Effect of NWT-03 on Blood Pressure

A Study of Two Parts to Determine the Effect of NWT-03 on Blood Pressure in Healthy Subjects

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
63 (actual)
Sponsor
Newtricious R&D BV · Industry
Sex
All
Age
35 Years – 75 Years
Healthy volunteers
Accepted

Summary

Part 2 of the study will assess the effect of 2g of NWT-03 (an egg-white protein hydrolysate) on systolic and diastolic blood pressure and flow-mediated dilation in a crossover designed study in healthy adults with mild hypertension.

Conditions

Interventions

TypeNameDescription
DIETARY_SUPPLEMENTNWT-03, an egg-white protein hydrolysateFor placebo comparator, a combination of sweetener + aroma, which was equal to the combination used in the intervention period, was given
DIETARY_SUPPLEMENTPlaceboA combination of sweetener + aroma , which was equal to the combination used in the intervention period, was given.

Timeline

Start date
2013-10-01
Primary completion
2014-04-01
First posted
2014-05-22
Last updated
2014-05-23

Locations

1 site across 1 country: Ireland

Source: ClinicalTrials.gov record NCT02144740. Inclusion in this directory is not an endorsement.